Loading stock data…
SOLV
$66.63-0.73 (-1.08%)
Market ClosedLast close May 1
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Solventum Corporation in the Healthcare sector is trading at $66.63. The stock is currently near its 52-week low of $62.38, remaining 9.8% below its 200-day moving average. Technical signals show neutral RSI of 47 and bearish MACD signal, explaining why SOLV maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 47) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$66.63
Potential Upside
150.6%
Whystock Fair Value$166.99
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus11 analysts
Buy
Mean target$84.18+26.3%
Range$60.00 – $105.00
Fundamentals
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Den...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$11.99B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
7.78
Beta
Defensive asset. Lower volatility than the S&P 500.
0.77
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
7.52%
Volume
Today's trading volume
1.03M
Recent News
How The Solventum (SOLV) Narrative Is Shifting With Mixed Analyst Targets And Model Resets
Solventum’s fair value price target has been adjusted slightly, moving from US$85.17 to US$84.18 per share, reflecting a modest reset in the underlying model. This change lines up with a mixed set of Street views, where some analysts see the current price as broadly in step with fundamentals, while others are more cautious and have trimmed their targets. As you read on, you will see how these differing opinions shape the evolving Solventum story and what that means for tracking the stock from...
CVS Q1 Earnings Preview: Health Services Likely to Lead Performance
CVS Health heads into Q1 earnings results with Health Services growth expected to offset pressure in benefits, as revenues dip slightly and costs remain elevated.
Labcorp Holdings (LH) Q1 Earnings and Revenues Top Estimates
Labcorp (LH) delivered earnings and revenue surprises of +3.81% and +1.03%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
SOLV vs. HQY: Which Stock Is the Better Value Option?
SOLV vs. HQY: Which Stock Is the Better Value Option?
3M Company (MMM): High-Margin Industrial Powerhouse Attracts Defensive Investors
We just covered the 14 Best Defensive Stocks to Invest In Now and 3M Company (NYSE:MMM) ranks 10th on this list. A major defensive catalyst for 3M Company (NYSE:MMM) is the successful separation of the healthcare business into Solventum. By spinning off its healthcare wing, finalized in 2024 and fully stabilized by early 2026, 3M […]